KERYX BIOPHARMACEUTICALS INC Increase (Decrease) in Accounts Receivable
KERYX BIOPHARMACEUTICALS INC reported Increase (Decrease) in Accounts Receivable of $6.46 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2018-11-08
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2018-09-30 was -$824.00K, a 211.50% decline year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2018-06-30 was $2.54M, a 10.19% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2018-03-31 was $4.74M, a 417.23% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2017-12-31 was -$1.05M, a 120.09% decline year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2017 was $2.91M, a 84.18% increase from fiscal 2016.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2016 was $1.58M, a 44.01% decline from fiscal 2015.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2015 was $2.82M, a 238.37% increase from fiscal 2014.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2014 was $834.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$824.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.72M derived: sum of 2 quarters · filed 2018-11-08 | $6.46M 10-Q · filed 2018-11-08 | $5.41M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $7.28M 10-Q · filed 2018-08-09 | $6.23M derived: sum of 3 quarters · filed 2018-08-09 | $6.97M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | $4.74M 10-Q · filed 2018-05-10 | $3.69M derived: sum of 2 quarters · filed 2018-05-10 | $4.43M derived: sum of 3 quarters · filed 2018-11-08 | $6.74M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$313.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.99M derived: sum of 3 quarters · filed 2018-11-08 | $2.91M 10-K · filed 2018-02-21 |
| 2017-09-30 | $739.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.04M derived: sum of 2 quarters · filed 2018-11-08 | $3.96M 10-Q · filed 2018-11-08 | $9.20M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.22M 10-Q · filed 2018-08-09 | $8.46M derived: sum of 3 quarters · filed 2018-08-09 | $3.36M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $917.00K 10-Q · filed 2018-05-10 | $6.15M derived: sum of 2 quarters · filed 2018-05-10 | $1.05M derived: sum of 3 quarters · filed 2018-05-10 | $1.83M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $135.00K derived: sum of 2 quarters · filed 2018-02-21 | $911.00K derived: sum of 3 quarters · filed 2018-02-21 | $1.58M 10-K · filed 2018-02-21 |
| 2016-09-30 | -$5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$4.33M derived: sum of 2 quarters · filed 2017-11-07 | -$3.66M 10-Q · filed 2017-11-07 | -$2.63M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | $776.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $1.45M 10-Q · filed 2017-07-27 | $2.47M derived: sum of 3 quarters · filed 2018-02-21 | $3.66M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $669.00K 10-Q · filed 2017-05-04 | $1.70M derived: sum of 2 quarters · filed 2018-02-21 | $2.89M derived: sum of 3 quarters · filed 2018-02-21 | $3.04M derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $2.22M derived: sum of 2 quarters · filed 2018-02-21 | $2.37M derived: sum of 3 quarters · filed 2018-02-21 | $2.82M 10-K · filed 2018-02-21 |
| 2015-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.34M derived: sum of 2 quarters · filed 2016-11-09 | $1.79M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $604.00K 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | $449.00K 10-Q · filed 2016-04-28 | |||
| 2014-12-31 | $834.00K 10-K · filed 2017-03-01 |